IMABI-Mab - ADR

$1.65
$0.155
(8.61%)
Today
Closed $1.65
$0.065
(3.95%)
After Hours
Updated: 07:58 PM EDT
Reported EarningsAug 20
Mkt Cap$189.8M
Vol598,677.00
50

Neutral Sentiment

How do you feel about IMAB?

About

NovaBridge Biosciences operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
30

Frequently Asked Questions

What is Market Cap of NovaBridge Biosciences. - ADR?
What is the 52-week high for NovaBridge Biosciences. - ADR?
What is the 52-week low for NovaBridge Biosciences. - ADR?
What is NovaBridge Biosciences. - ADR stock price today?
What was NovaBridge Biosciences. - ADR stock price yesterday?
What is the PE ratio of NovaBridge Biosciences. - ADR?
What is the Price-to-Book ratio of NovaBridge Biosciences. - ADR?
What is the 50-day moving average of NovaBridge Biosciences. - ADR?
How many employees does NovaBridge Biosciences. - ADR have?

Advertisement|Remove ads.